Human biliverdin reductase promotes EMT through the ERK1/2 signal pathway in breast cancer.

Abstract

Epithelial-to-mesenchymal transition (EMT) plays an important role in the development of the invasive and metastatic potentials of breast cancer cells during progression. Human biliverdin reductase (hBVR), an enzyme in the heme metabolism pathway, is involved in hypoxia-induced renal tubular EMT. However, whether hBVR contributes to the EMT of breast cancer remains unclear. Here, we used breast cancer cell lines (MCF-7, T-47D) and normal breast epithelial cells (MCF-10A) to explore the potential role of hBVR in the EMT of breast cancer. Western blot, RT-PCR and immunofluorescence were employed to test the expression and location of hBVR in the cell lines. Small interfering RNA of hBVR (si-hBVR) was used to knockdown the expression of hBVR, and U0126 was applied to inhibit the ERK1/2 signaling in MCF-7, T-47D cells. We found that hBVR highly expressed in MCF-7 and T-47D cells compared with MCF-10A cells, and had different cellular locations between them. Our results revealed that EMT occurred in tissues from breast cancer patients and breast cancer cell lines. However, the EMT in MCF-7 and T-47D cells was suppressed by si-hBVR and U0126. Furthermore, the expression of phosphorylated ERK1/2 was down-regulated by si-hBVR. In addition, hBVR regulated EMT through the ERK1/2 signaling, but bilirubin, which is a product of hBVR in the heme metabolism pathway in breast cancer, did not. Taken together, these findings provide new evidence that hBVR plays an important role in promoting EMT in human breast cancer through the ERK1/2 signaling pathway, and hBVR may be a therapeutic target for this disease.

• Authors: Min Zhang, Shasha Song, Zhi Yi, Xijuan Zhao, Li Fu, Lin Wang, Cui Ma, Min Mao, Yan Xing, Daling Zhu
• Journal: European journal of pharmacology (Eur J Pharmacol) Vol. 788 Pg. 45-53 (Oct 05 2016) ISSN: 1879-0712 [Electronic] Netherlands
• PMID: 27316791 (Publication Type: Journal Article)
• Copyright: Copyright © 2016 Elsevier B.V. All rights reserved.

Chemical References

• RNA, Small Interfering
• Oxidoreductases Acting on CH-CH Group Donors
• biliverdin reductase

Topics

• Breast Neoplasms (pathology)
• Cell Line, Tumor
• Epithelial-Mesenchymal Transition
• Gene Knockdown Techniques
• Humans
• MAP Kinase Signaling System
• Molecular Targeted Therapy
• Oxidoreductases Acting on CH-CH Group Donors (deficiency, genetics, metabolism)
• RNA, Small Interfering (genetics)
• Up-Regulation